11 – 18 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2007
-
Mark
The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: Towards a biologically-based screening strategy
(
- Contribution to journal › Article
- 2004
-
Mark
Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio
(
- Contribution to journal › Article
- 2001
-
Mark
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml
(
- Contribution to journal › Article
- 1999
-
Mark
Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells
(
- Contribution to journal › Article
- 1998
-
Mark
Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling
(
- Contribution to journal › Article
- 1996
-
Mark
Successful separation between benign prostatic hyperplasia and prostate cancer by measurement of free and complexed PSA
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 1992
-
Mark
Prostate specific antigen predominantly forms a complex with alpha1‐antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum
(
- Contribution to journal › Article
- 1988
-
Mark
Structure and function of prostatic- and seminal vesicle-secreted proteins involved in the gelation and liquefaction of human semen
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »